Clinical Trial

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

Name: Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis — clinical trial record (NCT01892722)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS)

Trial Details

NCT Number	NCT01892722
Lead Sponsor	Novartis Pharmaceuticals
Conditions	Multiple Sclerosis
Enrollment	240 participants
Start Date	2013-07-26
Primary Completion	2017-07-14 (estimated)
Study Completion	2030-02-18 (estimated)
Updated on ClinicalTrials.gov	2026-06-08